Annexin 1: Differential expression in tumor and mast cells in human larynx cancer

International Journal of Cancer

Volumn 120, Issue 12, 2007, Pages 2582-2589

  Silistino Souza, Rosana ^a,b   Rodrigues Lisoni, Flávia C ^c   Cury, Patricia M ^c   Maniglia, José V ^c   Raposo, Luis S ^c   Tajara, Eloiza H ^c   Christian, Helen C ^d   Oliani, Sonia M ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Faculty of Medicine   (Brazil)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Annexin 1; Hep 2 cells; Human mast cells; Larynx tumor; Ultrastructural immunocytochemistry

Indexed keywords

ANNEXIN; ANNEXIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LARYNX CANCER; LARYNX MUCOSA; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR CELL;

AGED; AGED, 80 AND OVER; ANNEXIN A1; CELL LINE, TUMOR; EPITHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNX; MALE; MAST CELLS; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRYPTASES;

EID: 34247538411     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22639     Document Type: Article

References (42)

1. Vokes EE, Stenson KM. Therapeutic options for laryngeal cancer. N Engl J Med 2003;349:2087-9.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Perretti M, Flower RJ. Modulation of IL-I induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993;150:992-9.
4. Flower RJ, Rothwell NJ. Lipocortin 1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994;15:71-6.
5. Diakonova M, Gerke V, Ernst J, Liautard JP, Van der Vusse G, Griffiths G. Localization of five annexins in J774 macrophages and isolated phagosomes. J Cell Sci 1997;110:1199-213.
6. Alldridge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK 1/2 MAPK signal. Exp Cell Res 2003;290:93-107.
7. Zhi H, Ding F, Wang M, Wu M, Liu Z. Suppression of growth and tumorigenicity in human esophageal carcinoma cell line EC9706 by overexpression of annexin A1. Annexins 2004; 1:121-8.
8. Pedrero JMG, Fernandez MP, Morgan RO, Zapatero AH, Gonzalez MV, Nieto CS, Rodrigo JP. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004;164:73-9.
9. De Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV 40 T large antigen transgenic mice. Hepatology 2000;31:371-80.
10. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang Q-H, Hu Net al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000;60:6293-7.
11. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 2001;98:9824-9.
12. Xin W, Rhodes DR, Ingold C, Chinnalyan AM, Rubin MA. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003;162:255-61.
13. Croxtall JD, Flower RJ. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci USA 1992;89:3571-5.
14. Loging WT, Lal A, Siu IM, Loney TL, Wikstrand CJ, Marra MA, Prange C, Bigner DD, Strausberg RL, Riggins GJ. Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res 2000;10:1393-402.
15. Ahn SH, Sawada H, Ro JY, Nicolson GL. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 1997;15: 151-6.
16. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001;61:889-95.
17. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 2005;326:218-27.
18. Oliani SM, Christian HC, Manston J, Flower RJ, Perretti M. An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest 2000;80:1429-38.
19. Bandeira-Melo C, Bonavita AGC, Diaz BL, Silva PMR, Carvalho VF, José PJ, Flower RJ, Perretti M, Martins MA. A novel effect for annexin 1-derived peptide Ac2-26: reduction of allergic inflammation in the rat. J Pharmacol Exp Ther 2005;313:1416-22.
20. Yu JL, Rak JW. Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res 2003;5:83-8.
21. Toth T, Toth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol 2000;31:955-60.
22. Peng SH, Deng H, Yang JF, Xie PP, Li C, Li H, Feng DY. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 2005;7:6521-4.
23. Kondo K, Muramatsu M, Okamoto Y, Jin D, Takai S, Tanigawa N, Miyazaki M. Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J Surg Oncol 2006;93:36-42.
24. Molin D, Edstrom A, Glimelius I, Glimelius B, Nilsson G, Sundstrom C, Emblad G. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 2002;119:122-4.
25. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004;25:235-41.
26. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning, a laboratory manual, 3th edn. New York: Cold Spring Harbor Laboratory Press, 2001, 999p.
27. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:1-12.
28. Gibbs L, Carollo MG, Damazo AS, Oliani SM, Perretti M. Time-dependent expression of leukocyte-associated annexin 1 in a model of chronic granulomatous inflammation. Inflamm Res 2002;51:300-6.
29. Hayes MJ, Moss SE. Annexins and disease. Biochem Biophys Res Commun 2004;322:1166-70.
30. Sato-Matsumura KC, Koizumi H, Matsumura T, Ohkawara A, Takasu T, Furata Y, Sawa H, Nagashima K. Localization of annexin I (lipocortin I, p35) mRNA in normal and diseased human skin by in situ hybridization. Arch Dermatol Res 1996;288:565-9.
31. Babbin BA, Lee WY, Parkos CA, Winfree M, Akyildiz A, Perretti M, Nusrat A. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 2006;201:19588-99.
32. Rodrigues-Lisoni FC, Mehet D, Peitl P, Jr, John C, Silva WA, Jr, Tajara EH, Buckingham J, Solito E. In vitro and in vivo studies on CCR10 regulation by Annexin A1. FEBS Lett 2006;580:1431-8.
33. Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, Perretti M. Increased apoptosis in U937 cells overexpressing lipocortin 1 (annexin 1). Life Sci 2000;66:265-70.
34. Solito E, De Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001;133:217-28.
35. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J 2003;17:1544-6.
36. Debret R, El Btaouri H, Duca L, Rahman I, Radke S, Haye B, Sallenave JM, Antonicelli E. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 2003;546:195-202.
37. Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E. Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death Differ 2005;12:1358-60.
38. Violette SM, King I, Browning JL, Pepinsky RB, Wallner BP, Sartorelli AC. Role of lipocortin 1 in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol 1990;142:70-7.
39. Cicek M, Samant RS, Kinter M, Welch DR, Casey G. Identification of metastasis associated proteins through protein analysis of meta-static MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 2004;21:149-57.
40. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:23-4.
41. Erbagci Z, Kerkilic S. Can smoking and/or occupational UV exposure have any role in the development of the morpheaform basal cell carcinoma? A critical role peritumoral mast cells. Int J Dermatol 2002; 41:275-8.
42. Damazo AS, Paul-Clark MJ, Straus AH, Takahashi HK, Perretti M, Oliani SM. Analysis of the annexin 1 expression in rat trachea: study of the mast cell heterogeneity. Annexins 2004;1:12-18.